3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Carcinoma, Hepatocellular
16
Carcinoma, Renal Cell
3
Biliary Tract Neoplasms
3
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Liver Neoplasms
2
Cholangiocarcinoma
2
Advanced Endometrial Cancer
2
Thyroid Neoplasms
1
Solid Tumors
1
Recurrence
1
Neoplasm Metastasis
1
Hepatitis B
1
Esophageal Squamous Cell Carcinoma
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Clear-cell metastatic renal cell carcinoma
1
Cirrhosis, Familial, with Pulmonary Hypertension
1
Breast Neoplasms
1
Bone Neoplasms
1
BTC
1
Advanced Triple Negative Breast Cancer
1
Advanced Non-squamous Non-small-cell Lung Cancer
1
Advanced Hepatocellular Carcinoma (HCC)
1
Adenocarcinoma
1
Interventions
lenvatinib
1
camrelizumab
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Advanced Triple Negative Breast Cancer
×
lenvatinib
×
Clear all
NCT06849492
2025-02-27
SHIFT-001
Fudan University
Phase 2
Not yet recruiting
120 enrolled